Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.34 USD | +1.23% | +39.59% | +22.97% |
16/04 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
11/04 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ANAPTYSBIO, INC. | Bio Therapeutic Drugs | +1.23% | +39.59% | +22.97% | +25.61% | -63.25% | 711M |
- Stock Market
- Equities
- ANAB Stock
- Charts AnaptysBio, Inc.
- Relative Strength Chart